Board of directors

Born: 1952.

Other current assignments: Rolfsen is board member of Cinclus Pharma Holding AB and Rolfsen Consulting AB (as of which she also is CEO). Rolfsen is partner in Serendipity Partners.

Experience: Rolfsen has 16 years’ experience in leading positions within pre-clinical research and development at Pharmacia AB. She has been responsible for the early clinical organization at Quintiles Europe and CEO of Quintiles Scandinavia for a total of 11 years. Moreover, she has been a board member of several listed companies since 2005. She holds a PhD in Pharmacology from Uppsala University where she also was associate professor during 9 years.

Independent of InDex and the senior management: Yes.

Independent of major shareholders: Yes.

Shareholding in InDex: Direct holding of 268 400 shares and indirect holding of 487 344 shares.

Born: 1976

Other current assignments: Forsell is board member of Nobia AB, STG Group AS, Kambi Group Plc, Lime Technologies AB and Addsecure.

Experience: Forsell was CFO for Swedish Match AB in 2013-2018 and previously held several leading financial positions in the same company. Before Forsell was employed by Swedish Match AB in 2004, she worked at Ernst & Young with transaction consulting. Forsell holds a Master of Business Administration degree from the Stockholm School of Economics.

Independent of InDex and the senior management: Yes.

Independent of major shareholders: Yes.

Shareholding in InDex: –

Born: 1950.

Other current assignments: Hacksell is chairman of the board of Medivir AB, Annexin Pharmaceuticals AB and SynAct Pharma AB, and board member of Active Biotech AB.

Experience: Hacksell has over 25 years of international R&D management experience from both large pharmaceutical and biotech companies as well as over 10 years of experience as public company CEO. Hacksell has been CEO and chairman of the board of Cerecor.Hacksell was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from being a private start-up to becoming a public multibillion dollar company. He has previously held various senior executive positions at Astra AB and has held the position of professor in organic chemistry at Uppsala University. He has a PhD from Uppsala University.

Independent of InDex and the senior management: Yes.

Independent of major shareholders: Yes.

Shareholding in InDex: Direct holding of 408 000 shares.

Born: 1956.

Other current assignments: Hansson is chairman of the board of Ignitus AB, Cinclus Pharma Holding AB and Sixera Pharma AB as well as board member of Medivir AB and QureTech Bio AB.

Experience: Former head of Life Science Investments at Industrifonden. Previously Hansson has more than 25 years’ experience from pharma and biotech industry in executive position at KabiGen, Symbicom AB, AstraZeneca AB, Karolinska Development AB and BioVitrum AB and as CEO for Arexis AB. He has a PhD from Umeå University.

Independent of InDex and the senior management: Yes.

Independent of major shareholders: Yes.

Shareholding in InDex: Indirect holding of 432 000 shares.

Born: 1963

Other current assignments: –

Experience: Bernadotte af Wisborg has more than 25 years of experience from the pharmaceutical industry. In 2015-2017, she was responsible for the Balkan region within MSD Europe and before that held several senior positions within the same organization, e.g. responsible for Public Affairs in Europe & Canada and CEO of MSD Sweden. She has been a board member of ContexVision, LIF in Sweden and AmCham Sweden. She holds a Master of Science in Pharmacy

Independent of InDex and the senior management: Yes.

Independent of major shareholders: Yes.

Shareholding in InDex: –

Born: 1968.

Other current assignments: –

Experience: Grönblad has more than 25 years of experience from the pharmaceutical industry. She has worked in various commercial roles in Sweden and the Nordic/Baltics with a focus on market access, launch preparations and organizational development. She was previously CEO of Sanofi AB and today works as Chief Commercial Officer at BioArctic AB. She has been a board member of the industry association LIF in Sweden and the Bariatric Center in Lund. Grönblad has a Bachelor of Science in Business Administration from Uppsala University.

Independent of InDex and the senior management: Yes.

Independent of major shareholders: Yes.

Shareholding in InDex: Direct holding of 50 000 shares